GROOVE BOTANICALS, INC.
GRVECIK 0000918573
Revenue (TTM)
—
Q3 Feb 2026
Net Income (TTM)
−$137.45K
+35.3% YoY
Q3 Feb 2026
EPS Diluted (TTM)
$0.00
0.0% YoY
Q3 Feb 2026
Gross Margin
—
Q3 Feb 2026
Operating Margin
—
Q3 Feb 2026
Net Margin
—
Q3 Feb 2026
Free Cash Flow (TTM)
—
Q3 Feb 2026
Cash
$1.49K
Q3 Feb 2026
Total Debt
$298.4K
Q3 Feb 2026
Shares Outstanding
59.64M sh
Q3 Feb 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.